Canada breast cancer diagnostics market is estimated to grow significantly at a CAGR of around 11.5% during the forecast period. The factors that influence the market growth in Canada include increasing the screening test for breast cancer and prevalence due to changes in life style. Breast cancer is the second leading cause of mortality in Canada. The incidence rate of breast cancer in Canada slightly increase with the increase in years. According to the Canadian Cancer Society about 26,300 women diagnosed with breast cancer in 2017. This accounts for 25% of all new cancer cases in women. The mortality due to breast cancer was about 5,000, which is 13% of all cancer mortality in women. On average 72 women in Canada were diagnosed and 14 women died with breast cancer every day. The breast cancer also happened in men about 230 men were diagnosed and mortality about 60 from breast cancer in 2017.
Get Free Sample link @ https://www.omrglobal.com/request-sample/canada-breast-cancer-diagnostics-market
Canada breast cancer diagnostics market is segmented on the basis of technology. Based on technology, the market is further classified into mammography, biopsy, position emission tomography/Computed tomography, ultrasound, and others. The mammography segment is projected to hold the largest share in the market. Mammography is a specific medical imaging technique that uses a low-dose x-ray system to see inside the breasts. A mammography exam, called a mammogram, aids in the early detection and diagnosis of breast diseases in women. The end-user segment market is further segregated into hospitals and diagnostics centers.
A full report of Canada Breast Cancer Diagnostics Market available @ https://www.omrglobal.com/industry-reports/canada-breast-cancer-diagnostics-market
- Market Coverage
- Market number available for – 2019-2025
- Base year- 2019
- Forecast period- 2020-2025
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Canada Breast Cancer Diagnostics Market by Technology
- Mammography
- Biopsy
- PET/CET
- Ultrasound
- Others (MRI)
Canada Breast Cancer Diagnostics Market by End-User
- Hospitals
- Diagnostics Centers
Company Profiles
- Agendia NV
- Becton, Dickinson and Co.
- Danaher Corp.
- General Electric Co.
- Hologic Inc.
- Johnson & Johnson Services Inc.
- Myriad Genetics, Inc.
- NanoString Technologies, Inc.
- Koninklijke Philips N.V.,
- Siemens Healthcare GmbH
The Report Covers
- Comprehensive research methodology of the Canada breast cancer diagnostics market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Canada breast cancer diagnostics market.
- Insights about market determinants which are stimulating the Canada breast cancer diagnostics market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/canada-breast-cancer-diagnostics-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
